SCHEMBL177846

SCHEMBL177846

CCCOP(=O)(Cl)OCCC

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP3A4 P08684 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TSHR P16473 3/20 0.36
LPAR3 Q9UBY5 4/20 0.36
LPAR1 Q92633 2/20 0.36
LPAR2 Q9HBW0 2/20 0.36
ALDH1A1 P00352 2/20 0.33
HMGCR P04035 1/20 0.33
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
LPAR5 Q9H1C0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL31005097 0.97 CYP3A4 (0.46) TP53TDP1CYP3A4MEN1KMT2A
SCHEMBL9128347 0.92 TP53 (0.52) TP53TDP1CYP3A4MEN1KMT2A
SCHEMBL10615316 0.92 TP53 (0.52) TP53TDP1CYP3A4MEN1KMT2A
SCHEMBL11415714 0.87
SCHEMBL11679523 0.87
SCHEMBL11213473 0.86 LPAR3 (0.57) CYP3A4LPAR3LPAR1LPAR2LPAR5
SCHEMBL31237057 0.84 TP53 (0.44) TP53TDP1CYP3A4MEN1KMT2A
SCHEMBL178128 0.83 CYP3A4 (0.64) TP53TDP1CYP3A4TSHRLPAR3
SCHEMBL3129990 0.82
SCHEMBL178106 0.81 LPAR3 (0.58) TP53TDP1CYP3A4TSHRLPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119350511-A Uranium thorium specific capture agent in complex solution system, synthesis method and application thereof 浙江创欣新材料有限公司 2025-01-24 CN claimed
CN-118772150-A Midazolam-D3 and preparation method thereof 上海原思标物科技有限公司 2024-10-15 CN claimed
US-20240336616-A1 MIDAZOLAM-D3 AND ITS PREPARATION METHOD SHANGHAI RESEARCH INSTITUTE OF CRIMINAL SCIENCE AND TECHNOLOGY (CN) 2024-10-10 US claimed
CN-116903910-B Metallized film for rail transit capacitor and preparation method thereof 河南华佳新材料技术有限公司 2023-12-01 CN claimed
CN-116903910-A Metallized film for rail transit capacitor and preparation method thereof 河南华佳新材料技术有限公司 2023-10-20 CN claimed
CN-116505072-A Lithium ion battery electrolyte and preparation method and application thereof 惠州锂威新能源科技有限公司 2023-07-28 CN claimed
CN-115286899-B Toughening-flame-retardant bisphenol type epoxy resin composite material and application thereof 上海汉禾生物新材料科技有限公司 2023-06-16 CN claimed
CN-113004321-B Method for desymmetrizing 3-substituted cyclobutanone, cyclobutene compound and application thereof 复旦大学 2022-07-29 CN claimed
CN-114773417-A Cordycepin phosphate and preparation method and application thereof 郑州大学 2022-07-22 CN claimed
CN-113004321-A Method for desymmetrizing 3-substituted cyclobutanone, cyclobutene compound and application thereof 复旦大学 2021-06-22 CN claimed
EP-1204157-B1 Electrolyte for non-aqueous batteries and secondary battery using the same PANASONIC CORP (JP) 2010-03-24 EP claimed
EP-1204157-A2 Electrolyte for non-aqueous batteries and secondary battery using the same MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2002-05-08 EP claimed
EP-4744667-A2 EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF The Queen's University Of Belfast (GB) 2026-05-20 EP disclosed
EP-4730479-A2 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME Kyoto University (JP) 2026-04-22 EP disclosed
US-20250246685-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME KYOTO UNIVERSITY (JP) 2025-07-31 US disclosed
US-20250163093-A1 EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2025-05-22 US disclosed
US-4065466-A Integrated process for the preparation of 2-dialkoxyphosphinylimino-1,3-dithietane AMERICAN CYANAMID COMPANY (US) 1977-12-27 US disclosed
US-4024277-A INSECTICIDE AND PESTICIDE FMC CORPORATION (US) 1977-05-17 US disclosed
US-3980644-A EXTRACTION WITH CYCLOHEXANONE ELI LILLY AND COMPANY (US) 1976-09-14 US disclosed
US-3961050-A Insecticidal compositions and methods of killing insects using benzylthiomethylenephosphonamidates and phosphoramidates VELSICOL CHEMICAL CORPORATION (US) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163093-A1 EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF NAPRT, NAMPT, CD38 TP53 3698/4885TDP1 629/4885CYP3A4 3598/4885
US-20240336616-A1 MIDAZOLAM-D3 AND ITS PREPARATION METHOD KCND3, DRD3, CYP3A43 TP53 3866/4885TDP1 4366/4885CYP3A4 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.